As it is possible that serpinA3 may have a different role depending on the pathophysiological scenery, we need to wait for serpinA3’s transgenic mice that will be soon available to more profoundly evaluate its role in AKI and CKD. This evidence concerns the gene SERPINA3 and chronic kidney disease.